Introduction
Gluten in the diet of coeliac disease (CD) patients causes histological alterations in their small bowel that may lead to disturbances in nutrient absorption, to symptoms such as diarrhoea and abdominal pain or to extraintestinal complications such as osteoporosis, infertility and cancer [1] . The treatment of CD consists of a lifelong glutenfree diet (GFD) to heal the duodenal mucosa, improve symptoms and protect from development of complications [2, 3] , although in some cases histological remission is incomplete [4] .
The treatment with a GFD has, in general, a positive effect on the patients' medical condition [1] , but results from the studies on the impact of treatment on their emotional and psychological well-being differ in outcome. The psychological well-being and health-related quality of life (HRQoL) of treated CD patients have been reported to be similar to healthy controls, both in children [5] and in adults [6, 7] . In contrast, a negative impact of CD on social life and a lower HRQoL in CD patients have also been described [8] [9] [10] [11] . Furthermore, sex differences seem to play a role in the HRQoL of CD patients, in particular being a disadvantage for women [6, 7, 12] .
The dietary compliance of CD patients has frequently been studied [13, 14] and compliance with the GFD may be one of the factors associated with HRQoL [7, 9] . It is known that HRQoL improves once newly clinically diagnosed CD patients are treated with a GFD [15, 16] , although in CD patients detected by screening this is not always the case [17] . Some patients, however, stop following the GFD and remain consuming gluten for a long time with good clinical tolerance to the challenge [18, 19] . In our study, on possible development of tolerance to gluten among adult CD patients, we found that 23% of them did not adhere to the GFD [19] . The aim of this study was to investigate whether the HRQoL was associated with the dietary (nondietary) compliance in the group of CD patients recruited for the study.
Patients and methods
Adult CD patients known to have CD for at least 10 years and diagnosed at the Leiden University Medical Center were invited to participate.
Dietary compliance
Dietary information was obtained by a questionnaire in which the patients were asked to register their degree of compliance with the diet as strict, partial or none. The consumption of gluten-containing products was checked by a food frequency questionnaire. The food frequency questionnaire for this study was developed according to the database of the Dutch Food consumption study, held in 1998 [20] , and according to the Dutch Food composition table [21] . Gluten intake was estimated by multiplying the grams of vegetable protein from glutencontaining cereals by 0.8 [22] . On the basis of gluten intake, three groups were distinguished: (i) GFD, (ii) gluten transgression ( < 10 g gluten/day), and (iii) normal gluten-containing diet (GCD, > 10 g gluten/day) [23] .
Blood tests
Participants were asked to have blood samples taken either at our hospital or at their family doctor's office. Titers of serum IgA against gliadin (AGA), tissue transglutaminase (tTGA) and endomysium were measured, using enzyme-linked immunosorbent assay techniques and indirect immunofluorescence on monkey oesophagus (B.M.E. Von Blomberg, Laboratory for clinical immunology, Free University Hospital, Amsterdam), respectively [24, 25] . Patients with a total IgA concentration less than 0.06 g/l were considered as IgA deficient. In these cases serum IgG AGA and IgG tTGA were measured.
Assessment of the health-related quality of life
The Short Form-36 (SF-36) health survey was used to assess the general HRQoL [26] . It is composed of 36 questions and standardized response choices, organized into eight multi-item scales: physical functioning, role limitations due to physical health problems, bodily pain, general health perception, vitality, social functioning, role limitations due to emotional problems and general mental health.
Comparison with the general population
Data from a random, nationwide sample in the Netherlands (1742 respondents, 56% male, age 16-94 years) were used as a reference to compare the results of the SF-36 [26] .
Assessment of symptoms
Specific gastrointestinal symptoms were evaluated according to the Gastrointestinal Symptom Rating Scale (GSRS), which rates gastrointestinal symptoms from 1 'no discomfort at all' to 7 'very severe discomfort' [27] .
Statistics
Statistics were performed by means of SPSS for Windows version 14.0 (SPSS Inc., Chicago, Illinois, USA). To compare patient characteristics and results, the KruskallWallis and Mann-Whitney U tests were used for skewed distribution and the analysis of variance and Student's t-test for normal distribution. Numbers of patients were compared using the Fisher's exact test. P values less than 0.05 were considered as significant. The internal consistency of the SF-36 and the GSRS was evaluated using Cronbach's a, and a value of 0.7 or higher was considered to represent adequate reliability. For better comparison, the results of all the items of the SF-36 were recoded in the same direction and transformed into a scale of 0-100. Results of the SF-36 and the GSRS are presented as means (standard deviation). By using the data from the general population [26] , we calculated expected values of the items of the SF-36, based on the distribution of age, sex and the total number of chronic health conditions of our sample. Mean scale scores of the SF-36 and the GSRS were corrected for group differences in age, sex and presence of chronic health conditions by multivariate regression analyses. Selective IgA deficiency was not considered as a condition to play a role in the HRQoL and thus was not corrected. A 95% confidence interval was used to compare the results of the SF-36 with the general population.
Ethics
The study protocol was approved by the Medical Ethics Committee of the Leiden University Medical Center.
Results
Of the 77 CD patients eligible to be invited for participation in the original study on possible development of tolerance to gluten [19] , 66 gave informed consent. In 13 of them, CD could not be confirmed by revision of the diagnostic biopsy, and only the remaining 53 patients with biopsy-confirmed CD participated in the study. Their characteristics, grouped according to their dietary habits, are presented in Table 1 . All, except one patient in the gluten transgression group, had gastrointestinal symptoms at diagnosis.
An associated chronic health condition was reported 27 times (by 32% of the patients). Some patients had more than one associated disease. Divided over the three diet groups, there were patients with selective IgA deficiency (n=5), hypothyroidism (n=4), dermatitis herpetiformis (n=3), diabetes mellitus type 1 (n=2), rheumatoid arthritis (n=2), Sjögren's syndrome (n=2), cancer (n=2), secondary hyperparathyroidism (n=1), ulcerative colitis (n=1), multiple sclerosis (n=1), systemic lupus erythematosus (n=1), scleroderma (n=1), fertility problems (n=1) and miscarriages (n=1). There were no significant differences in the distribution of patients with an associated chronic health condition among the three groups (Table 1) .
Dietary compliance
The self-reported strict compliance with the GFD was 62% (33 of 53). Twelve patients (23%) reported to consume a normal GCD and eight reported to consume low amounts of gluten (gluten transgression). The patients with a GCD reported that the reasons for restarting gluten consumption were from medical advice because 'according to the doctor CD was cured' (n=4) or because they experienced 'no complaints after gluten ingestion' (n=8).
The duration of CD was comparable in all the three groups. The patients consuming gluten (GCD or gluten transgression) were, however, diagnosed with CD at a significant younger age and are presently significantly younger than the ones strictly adhering to a GFD (Table 1 ).
Blood tests
Forty-six of the 53 participating patients (87%) consented to venipuncture. Five patients were IgA deficient: one of them (GCD) had IgG AGA and another one (GFD) had IgG tTGA. IgA positivity for CD antibodies was found in four of 41 patients (10%). A significant difference was found in the number of patients with positive IgA-endomysium among the three dietary groups (P=0.043) [19] .
Short Form-36 health survey
The internal consistency of the SF-36 subscales ranged from 0.77 to 0.95. Results of the SF-36 are presented in Tables 2 and 3 .
Comparing the HRQoL of the three groups of CD patients with different dietary compliance, significantly better scores were found in the patients consuming gluten: better general mental health in patients with gluten transgression and less bodily pain in patients with a GCD. These differences, however, disappeared when the comparisons were corrected for age, sex and presence of associated chronic health conditions (Table 2 ).
Overall, corrected for age and sex (Table 3) , CD patients reported significantly worse general health perception but significantly better HRQoL for the domains bodily pain and limitations due to physical problems compared with the general population. When corrected for the presence or absence of chronic health conditions, the general health perception did not differ between CD patients and the reference population, but CD patients showed significantly higher scores for the domains' physical functioning, bodily pain, limitations due to physical problems and limitations due to emotional problems (Table 3) . Gluten-containing diet, > 10 g gluten/day; gluten-free diet, no gluten/day; gluten transgression, < 10 g gluten/day. BMI, body mass index; GCD, gluten-containing diet; GFD, gluten-free diet; GT, gluten transgression. *Significance between GFD and GT. **Significance between GFD and GCD. ***Significance between GT and GCD. 
Gastrointestinal Symptom Rating Scale
The internal consistency of the GSRS subdimensions ranged from 0.64 to 0.92. Results of the GSRS are presented in Table 4 . No significant differences were found in the mean scores of the GSRS between the different dietary groups, corrected for age, sex or associated chronic health conditions.
Discussion
In this study, among CD patients with and without adherence to the GFD, we found a similar HRQoL in patients with different dietary compliance. Our findings are in agreement with an earlier report on Swedish patients [12] , but are in contrast with the better HRQoL found in the Italian patients with better dietary compliance [9] . In the latter study, however, patients had a shorter duration of CD (e.g. 2 years) possibly explaining their better HRQoL.
One of the factors associated with HRQoL in CD patients may be the presence or absence of symptoms [16] . Considering the gastrointestinal symptoms scored by GSRS, we did not find differences among the three groups of patients with different dietary compliance. This similarity of the GSRS scores may partly explain the similarity in HRQoL between the three dietary groups. In contrast, it is possible that the GSRS is not sensitive enough as it was not specifically designed to study symptoms in CD patients, although in earlier studies, the instrument was found to be effective in discriminating symptom scores between male and female CD patients [12, 28] and between CD patients at diagnosis and after 1-year follow-up on a GFD [29] . Although, in general, the most common reason for persistent symptoms in CD patients is gluten exposure, our results show that in some patients the presence of symptoms is not associated with dietary compliance and that patients adhering to a strict GFD for several years may continue to have gastrointestinal symptoms [12, 28, 30] .
The risk of CD-related comorbidity or potential complications are other factors associated with HRQoL [16] and can be measured with the item 'I expect my health to deteriorate' as part of the general health perception domain of the SF-36. In our study, we did not find significant differences in this domain among the three dietary groups. Furthermore, we were able to compare CD patients with associated chronic health conditions already present with CD patients without these and found comparable SF-36 scores (data not shown). Psychiatric disorders common in coeliac populations, such as anxiety and depression, are other factors that can affect HRQoL, but these aspects are not measured by SF-36 and GSRS, so we cannot exclude that this comorbidity is more or less present in the different dietary compliance groups.
The HRQoL might also be associated with factors not related to CD. It is known that, concerning the results of the SF-36, older respondents generally score significantly lower than younger respondents and women have lower scores than men [26] . In our study, the patients adhering to the GFD tended to have lower HRQoL scores than the other groups, but this apparent difference can be explained because the group was older and contained a higher percentage of females.
When comparing HRQoL of the CD patients in general with the reference population, coeliac patients showed worse general health perception, confirming earlier studies [9, 10, 12] , but they had better scores concerning the physical domains. More precisely, the coeliac patients score significantly worse on general health compared with the general population corrected for age and sex but scored equal on general health when compared with the general population corrected for the presence of chronic health conditions, which seems logical. In contrast, the remaining scales show equal or better scores in the coeliac patients compared with the general population. This apparent discrepancy may be explained by the fact that the multi-item scale 'general health perception' contains questions covering the current and future situations, in contrast to the other multi-item scales covering only questions about the present situation. Another explanation of the apparent discrepancy might be that the general health perception scale demands a general answer, whereas the other scales of the SF-36 question specific functions and symptoms of which answers may differ. In contrast, presumably, CD patients, once diagnosed and treated, experience their newfound vitality and health as a relief, as has been reported by patients 10 years after the diagnosis [31] , which may positively influence the interpretation of the questions of the SF-36.
The interest within the medical community in measuring quality of life (QoL) is increasing [7] [8] [9] [10] [11] [12] 17, 32, 33] . It has been argued that what matters in HRQoL is the way patients feel about their functioning, not their functioning itself [34] . The subjective assessment of physical, mental and social dimensions of well being and social functioning can be performed by generic or diseasespecific instruments. In this study, we have used the SF-36. Being a generic instrument for QoL measurement, the SF-36 can be used to measure the impact of treatment on HRQoL but not to measure the diseasespecific QoL aspects such as, in the case of CD, the possible social and financial restrictions because of the GFD. Therefore, the use of both generic and diseasespecific instruments is recommended to assess the HRQoL [35] . Recently, disease-specific instruments to assess HRQoL in coeliac patients have been developed and validated, both for adults (Coeliac Disease Questionnaire) [36] and for children (Coeliac Disease Dutch Quality of Life Instrument for Children and Parentsas-Proxy) [11] .
In light of upcoming developments for new treatment strategies for CD [37] [38] [39] [40] , the comparison of HRQoL of coeliac patients with current and alternative treatment will be necessary in the future to obtain information on which treatment, under which circumstances will be most appreciated. The disease-specific instruments to assess HRQoL in CD may be valuable tools for the caregivers to get information on the HRQoL of adult and paediatric CD patients aiming to ameliorate their treatment.
Limitations of our study were that the CD patients were originally invited to participate in a study on the possible development of tolerance to gluten [19] . It is possible that the patients willing to participate were either the patients who consume gluten and want to show other CD patients that consuming gluten does not give them any health problems, or the patients on a GFD who try to find a way to get off the diet by participating in this study. Furthermore, the study was performed among a limited number of patients and they were all diagnosed at the same university hospital. Therefore, further studies are needed to confirm our results in larger and less specifically selected samples of CD patients. Another limitation concerns the corrections made for age, sex and presence of a chronic health condition, that could only be matched separately with the data available from the reference population.
In conclusion, the HRQoL of the chronic ill patients is an important factor in his treatment. Equally important is the prevention of comorbidity and complications of CD patients, achieved by strict adherence to the GFD. We and others found that strict adherence to the GFD does not have negative consequences for the HRQoL, hence, strict adherence to the GFD should be advised to all the CD patients.
